Open AccessCIB1 depletion with docetaxel or TRAIL enhances triple-negative breast cancer cell death
Author(s) -
Alexander H. Chung,
Tina M. Leisner,
Gabrielle J Dardis,
Marissa M Bivins,
Alana L. Keller,
Leslie V. Parise
Publication year - 2019
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/6gqw-4v64
Subject(s) - docetaxel , triple negative breast cancer , breast cancer , medicine , oncology , cancer research , programmed cell death , cancer , apoptosis , biology , biochemistry